cyclopentane has been researched along with Angioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbiser, JL; Augustin, HG; Benest, AV; Bhandarkar, SS; Bonner, MY; Fried, LE; Govindarajan, B; Jaconi, M; Knaus, U; Lefkove, B; Mackelfresh, J; Parhar, R; Perry, BN; Reiss, Y; Sohn, A; Stouffs, M; Yancopoulos, G | 1 |
1 other study(ies) available for cyclopentane and Angioma
| Article | Year |
|---|---|
Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice.
Topics: Angiopoietin-2; Animals; Cyclopentanes; Endothelial Cells; Enzyme Inhibitors; Hemangioma; Intracellular Signaling Peptides and Proteins; Mice; NADPH Oxidase 4; NADPH Oxidases; Proteins; Vascular Endothelial Growth Factor A | 2009 |